Jeff Black

(Mr. Jeffrey Black)

Currently holds positions in Alphatec Holdings Inc and BASF Enzymes LLC

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Alphatec Holdings Inc March 6, 2017 -
Chief Financial Officer, Senior Vice President BASF Enzymes LLC March 31, 2011 -
Jeff Black's trades of Exagen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-19 2024-11-15
US Exagen Inc (XGN)
B Purchase
22,298 +8.8%
2.98
USD 66,448 		22,298 +8.8% 2.98 USD 66,448
2023-05-22 2023-05-19
US Fluidigm Corp (FLDM)
B Purchase
42,492 +97.7%
2.29
USD 97,213 		42,492 +97.7% 2.29 USD 97,213
2023-05-22 2023-05-18
US Fluidigm Corp (FLDM)
B Purchase
43,492 +inf%
2.22
USD 96,365 		43,492 +inf% 2.22 USD 96,365
2022-03-01 2022-03-01
B Purchase
10,000 +3.9%
6.20
USD 62,000 		10,000 +3.9% 6.20 USD 62,000
2022-03-01 2022-02-28
B Purchase
15,000 +6.2%
5.66
USD 84,900 		15,000 +6.2% 5.66 USD 84,900
2022-03-01 2022-02-25
B Purchase
15,000 +6.7%
5.48
USD 82,200 		15,000 +6.7% 5.48 USD 82,200
2021-03-10 2021-03-09
PS Planned sale
7,000 -1.1%
16.69
USD 116,830 		7,000 -1.1% 16.69 USD 116,830
2021-02-18 2021-02-16
PS Planned sale
25,000 -3.8%
16.28
USD 407,000 		25,000 -3.8% 16.28 USD 407,000
2020-08-13 2020-08-11
S Sale
5,000 -0.8%
6.42
USD 32,100 		5,000 -0.8% 6.42 USD 32,100
2020-08-06 2020-08-04
PS Planned sale
8,929 -1.3%
5.03
USD 44,913 		8,929 -1.3% 5.03 USD 44,913
2020-03-12 2020-03-10
PS Planned sale
6,563 -1.3%
5.08
USD 33,307 		6,563 -1.3% 5.08 USD 33,307
// ... existing code ... // ... rest of the file ...